Cowen Prime Advisors LLC Novartis Ag Transaction History
Cowen Prime Advisors LLC
- $287 Million
- Q2 2023
A detailed history of Cowen Prime Advisors LLC transactions in Novartis Ag stock. As of the latest transaction made, Cowen Prime Advisors LLC holds 100 shares of NVS stock, worth $10,341. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$10,341
Previous $10,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,425Shares Held
131MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.26 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.24 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$837 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$722 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$597 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $222B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...